Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/49087
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFuxe, Kjell-
dc.contributor.authorBorroto Escuela, Dasiel Oscar-
dc.contributor.authorRomero Fernández, Wilber-
dc.contributor.authorTarakanov, Alexander O.-
dc.contributor.authorCalvo, Feliciano-
dc.contributor.authorGarriga, Pere-
dc.contributor.authorTena, Mercé-
dc.contributor.authorNarváez, Manuel-
dc.contributor.authorMillón, Carmelo-
dc.contributor.authorParrado, Concepción-
dc.contributor.authorCiruela Alférez, Francisco-
dc.contributor.authorAgnati, Luigi F.-
dc.contributor.authorNarváez, José A.-
dc.contributor.authorDíaz Cabiale, Zaida-
dc.date.accessioned2014-01-22T10:05:24Z-
dc.date.available2014-01-22T10:05:24Z-
dc.date.issued2012-10-26-
dc.identifier.issn1664-2392-
dc.identifier.urihttp://hdl.handle.net/2445/49087-
dc.description.abstractGalanin receptor (GalR) subtypes 1-3 linked to central galanin neurons may form heteromers with each other and other types of G protein-coupled receptors in the central nervous system (CNS). These heteromers may be one molecular mechanism for galanin peptides and their N-terminal fragments (gal 1-15) to modulate the function of different types of glia-neuronal networks in the CNS, especially the emotional and the cardiovascular networks. GalR-5-HT1A heteromers likely exist with antagonistic GalR-5-HT1A receptor-receptor interactions in the ascending midbrain raphe 5-HT neuron systems and their target regions. They represent a novel target for antidepressant drugs. Evidence is given for the existence of GalR1-5-HT1A heteromers in cellular models with trans-inhibition of the protomer signaling. A GalR1-GalR2 heteromer is proposed to be a galanin N-terminal fragment preferring receptor (1-15) in the CNS. Furthermore, a GalR1-GalR2-5-HT1A heterotrimer is postulated to explain why only galanin (1-15) but not galanin (1-29) can antagonistically modulate the 5-HT1A receptors in the dorsal hippocampus rich in gal fragment binding sites. The results underline a putative role of different types of GalR-5-HT1A heteroreceptor complexes in depression. GalR antagonists may also have therapeutic actions in depression by blocking the antagonistic GalR-NPYY1 receptor interactions in putative GalR-NPYY1 receptor heteromers in the CNS resulting in increases in NPYY1 transmission and antidepressant effects. In contrast the galanin fragment receptor (a postulated GalR1-GalR2 heteromer) appears to be linked to the NPYY2 receptor enhancing the affinity of the NPYY2 binding sites in a putative GalR1-GalR2-NPYY2 heterotrimer. Finally, putative GalR-α2-adrenoreceptor heteromers with antagonistic receptor-receptor interactions may be a widespread mechanism in the CNS for integration of galanin and noradrenaline signals also of likely relevance for depression-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3389/fendo.2012.00127-
dc.relation.ispartofFrontiers in Endocrinology, 2012, vol. 3, p. 1-12-
dc.relation.urihttp://dx.doi.org/10.3389/fendo.2012.00127-
dc.rightscc-by (c) Fuxe, Kjell et al., 2012-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationReceptors de serotonina-
dc.subject.classificationSistema nerviós central-
dc.subject.classificationProteïnes G-
dc.subject.otherSerotonin receptors-
dc.subject.otherCentral nervous system-
dc.subject.otherG Proteins-
dc.titleOn the existence and function of galanin receptor heteromers in the central nervous system-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec617235-
dc.date.updated2014-01-22T10:05:24Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid23112793-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
617235.pdf984.89 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons